Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor

  • Authors:
    • Ning Zhang
    • Pengjie Wu
    • Duoerkun Shayiremu
    • Liyang Wu
    • Hui Shan
    • Lin Ye
    • Xueqin Zhao
    • Jie Cai
    • Wen Guo Jiang
    • Kan Gong
    • Yong Yang
  • View Affiliations

  • Published online on: March 29, 2013     https://doi.org/10.3892/ijo.2013.1877
  • Pages: 1664-1673
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Vascular endothelial growth inhibitor (VEGI) has been associated with tumor-related vasculature in certain malignancies. However, its implication in renal cell carcinoma (RCC), an angiogenesis-dependent tumor, remains unknown. In the present study, we investigated the role played by VEGI in RCC. The expression of VEGI was examined in human renal tissue and RCC cell lines using immunohistochemical staining and RT-PCR, respectively. The biological impact of modifying the expression of VEGI in RCC cells was evaluated using in vitro and in vivo models. We show that VEGI mRNA is expressed in a wide variety of human RCC cell lines, all of normal renal and most of RCC tissue specimens. VEGI protein expression was observed in normal renal tubular epithelial cells, but was decreased or absent in RCC specimens, particularly in tumors with high grade. Moreover, forced expression of VEGI led to an inhibition of vascular endothelial tube formation, decrease in the motility and adhesion of RCC cells in vitro. Interestingly, forced expression of VEGI had no bearing on growth, apoptosis and invasive capacity of RCC cells. However, tumor growth was reduced in xenograft models. Immunohistochemical staining showed that microvessel density decreased in VEGI forced expression xenograft tumor samples. Taken together, our findings showed that the expression of VEGI is decreased in RCC, particularly in tumors with higher grade. Together with its inhibitory effect on cellular motility, adhesion, vascular endothelial tube formation and tumor growth in vivo, this suggests that VEGI functions mainly through inhibition of angiogenesis and is a negative regulator of aggressiveness during the development and progression of RCC.
View Figures
View References

Related Articles

Journal Cover

May 2013
Volume 42 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang N, Wu P, Shayiremu D, Wu L, Shan H, Ye L, Zhao X, Cai J, Jiang WG, Gong K, Gong K, et al: Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor. Int J Oncol 42: 1664-1673, 2013
APA
Zhang, N., Wu, P., Shayiremu, D., Wu, L., Shan, H., Ye, L. ... Yang, Y. (2013). Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor. International Journal of Oncology, 42, 1664-1673. https://doi.org/10.3892/ijo.2013.1877
MLA
Zhang, N., Wu, P., Shayiremu, D., Wu, L., Shan, H., Ye, L., Zhao, X., Cai, J., Jiang, W. G., Gong, K., Yang, Y."Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor". International Journal of Oncology 42.5 (2013): 1664-1673.
Chicago
Zhang, N., Wu, P., Shayiremu, D., Wu, L., Shan, H., Ye, L., Zhao, X., Cai, J., Jiang, W. G., Gong, K., Yang, Y."Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor". International Journal of Oncology 42, no. 5 (2013): 1664-1673. https://doi.org/10.3892/ijo.2013.1877